Form 8-K - Current report:
SEC Accession No. 0001193125-19-003893
Filing Date
2019-01-07
Accepted
2019-01-07 17:10:32
Documents
1
Period of Report
2019-01-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d685683d8k.htm 8-K 15852
  Complete submission text file 0001193125-19-003893.txt   17345
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 19513991
SIC: 2834 Pharmaceutical Preparations